[重度の産婦人出血および重度のトラウマにおける拡散性血管内凝固]
1Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|September 3, 2025
まとめ
産科およびトラウマにおける拡散性血管内凝固 (DIC) は,ハイパーフィブリノリシスと出血を伴う. 治療は凝固因子の置換と生存を改善するために抗フィブリノリート療法を使用することに焦点を当てています.
科学分野:
- 血液学
- 産婦人科
- トラウマ 手術
背景:
- 分散性血管内凝固 (DIC) は生命を脅かす状態です.
- 産科性DICは胎盤/胎児組織因子に起因し,外傷性DICは内皮損傷を伴う.
- この2つの状態は 消費性凝固症とハイパーフィブリノリシスで出血が悪化します
研究 の 目的:
- 重症産婦人出血と重度のトラウマで DICを分類する
- 産科およびトラウマ関連のDICの明確な病理的トリガーを解明する.
- これらのDICの共通点と治療戦略を強調する.
主な方法:
- DICの病理的分類と進行
- 産科および外傷によるDICにおけるエチオロジック要因の分析
- ハイパーフィブリノリシスによるDICの治療戦略のレビュー
主要な成果:
- 産科とトラウマにおけるDICは,繊維分解性および急性に分類されます.
- 産科性DICは胎盤,胎盤液,乳房からの組織因子によって引き起こされます.
- トラウマ-DICは,特にトラウマ性脳損傷から,血管内皮損傷と組織因子を伴う.
結論:
- DICの有効な管理には,凝固因子置換と抗フィブリノリート療法が必要です.
- これらの介入は,ハイパーフィブリノリシスの制御と大量出血の減少に不可欠です.
- DIC患者の生存率を向上させることができます.
関連する概念動画
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889


